Roth Capital Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $8

Roth Capital analyst Scott Fortune initiates coverage on IM Cannabis (NASDAQ:IMCC) with a Buy rating and announces Price Target of $8.